Wolff Wiese Magana’s Regeneron Pharmaceuticals REGN Stock Holding History

Wolff Wiese Magana’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.5K	Hold	4	–	–	﹤0.01%	786
2026 Q1	$3.09K	Hold	4	–	–	﹤0.01%	699
2025 Q4	$3.09K	Hold	4	–	–	﹤0.01%	671
2025 Q3	$2.25K	Buy	4 +2	+100%	+$1.13K	﹤0.01%	737
2025 Q2	$1.05K	Sell	2 -7	-78%	-$3.91K	﹤0.01%	835
2025 Q1	$5.71K	Buy	9 +1	+13%	+$688	﹤0.01%	523
2024 Q4	$5.7K	Hold	8	–	–	﹤0.01%	525
2024 Q3	$8.41K	Buy	8 +6	+300%	+$6.68K	0.01%	478
2024 Q2	$2.1K	Buy	2 +1	+100%	+$969	﹤0.01%	539
2024 Q1	$963	Hold	1	–	–	﹤0.01%	576
2023 Q4	$879	Hold	1	–	–	﹤0.01%	566
2023 Q3	$823	Hold	1	–	–	﹤0.01%	638
2023 Q2	$719	Hold	1	–	–	﹤0.01%	642
2023 Q1	$822	Sell	1 -1	-50%	-$754	﹤0.01%	594
2022 Q4	$1.44K	Buy	2 +1	+100%	+$738	﹤0.01%	535
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	787
2022 Q2	$1K	Sell	1 -6	-86%	-$3.9K	﹤0.01%	807
2022 Q1	$5K	Hold	7	–	–	﹤0.01%	642
2021 Q4	$4K	Hold	7	–	–	﹤0.01%	669
2021 Q3	$4K	Buy	7 +4	+133%	+$2.48K	﹤0.01%	652
2021 Q2	$2K	Buy	+3	New	+$1.52K	﹤0.01%	739

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wolff Wiese Magana's REGN Position: Q2 2026 in Review

Wolff Wiese Magana held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 4 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Wolff Wiese Magana first reported a position in REGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $8.41K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Wolff Wiese Magana held 4 shares of Regeneron Pharmaceuticals worth $2.5K as of Q2 2026.
Wolff Wiese Magana left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #786 holding.
Wolff Wiese Magana first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
Wolff Wiese Magana's Regeneron Pharmaceuticals position peaked at $8.41K in Q3 2024.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.